Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus
Expert Review of Clinical Pharmacology · 2025
DOI: 10.1080/17512433.2025.2573783 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Mayalen Uthurriague und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU de Bordeaux, Bordeaux, France. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Pregnancy Complications. Die Arbeit nennt 158 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Pregnancy in women with systemic lupus erythematosus presents significant clinical challenges due to heightened risks of complications for both mother and fetus. Therapeutic management must be carefully tailored to safeguard maternal health while ensuring optimal fetal development. AREAS COVERED: This review explores pharmacological treatments used during pregnancy in women with lupus, focusing on medication safety profiles, risk-benefit analyses of available therapeutic options, and specific challenges posed by comorbidities such as antiphospholipid syndrome and vaccination considerations. EXPERT OPINION: Although significant advances have been made in managing lupus during pregnancy, many treatments, particularly biologic therapies, still lack sufficient evidence for unrestricted use. This underscores the necessity for vigilant monitoring and individualized treatment protocols. Preconception consultation remains crucial for optimizing therapeutic strategies, ensuring appropriate medication adjustments prior to conception. A coordinated multidisciplinary approach is essential to navigate these complexities and achieve favorable outcomes for both mother and child.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU de Bordeaux, Bordeaux, France.
- UMR/CNRS 5164, immunoconcept, CNRS, University of Bordeaux, Bordeaux, France.
- Department of Internal Medicine and Infectious Diseases, Centre National de Référence des Maladies Auto-Immunes Systémiques Rares RESO, CHU Bordeaux, Pessac, France.
- Department of Immunology and Immunogenetics, CHU Bordeaux, Bordeaux, France.
- Department of Internal Medicine and Clinical Immunology, CHU Bordeaux, Bordeaux, France.
ORCID-Profile: Mayalen Uthurriague, Estibaliz Lazaro, Christophe Richez, Patrick Blanco, Noémie Gensous
Zitieren
APA
Uthurriague, M., Lazaro, E., Richez, C., Blanco, P., & Gensous, N. (2025). Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2573783
Vancouver
Uthurriague M, Lazaro E, Richez C, Blanco P, Gensous N. Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2573783
BibTeX
@article{Uthurriague2025,
author = {Uthurriague, Mayalen and Lazaro, Estibaliz and Richez, Christophe and Blanco, Patrick and Gensous, Noémie},
title = {Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
doi = {10.1080/17512433.2025.2573783}
}
EUVIMED